<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Paired Helical Filaments of Inclusion-Body Myositis Muscle Contain RNA and Survival Motor Neuron Protein</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Aldobrando</forename><surname>Broccolini</surname></persName>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">King</forename><surname>Engel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Renate</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
							<email>askanas@hsc.usc.edu</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution" key="instit1">University of Southern California Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">University of Southern California Keck School of Medicine</orgName>
								<orgName type="institution" key="instit3">Good Samaritan Hospital</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<country>California</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">USC Neuromuscular Center</orgName>
								<address>
									<addrLine>637 South Lucas Avenue</addrLine>
									<postCode>90017-1912</postCode>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Paired Helical Filaments of Inclusion-Body Myositis Muscle Contain RNA and Survival Motor Neuron Protein</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">699EEEF92198FBDD770E1C38F8C25793</idno>
					<note type="submission">Accepted for publication December 9, 1999.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sporadic inclusion-body myositis (s-IBM) is the most common progressive muscle disease of older persons. Pathologically, the muscle biopsy manifests various degrees of inflammation and specific vacuolar degeneration of muscle fibers characterized by paired helical filaments (PHFs) composed of phosphorylated tau. IBM vacuolated fibers also contain accumulations of several other Alzheimer-characteristic proteins.</head><p>Molecular mechanisms leading to formation of the PHFs and accumulations of proteins in IBM muscle are not known. We report that the abnormal muscle fibers of IBM contained (i) acridine-orange-positive RNA inclusions that colocalized with the immunoreactivity of phosphorylated tau and (ii) survival motor neuron protein immunoreactive inclusions, which by immuno-electron microscopy were confined to paired helical filaments. This study demonstrates two novel components of the IBM paired helical filaments, which may lead to better understanding of their pathogenesis.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Sporadic inclusion-body myositis (s-IBM), the most common muscle disease of older persons, leads to severe disability. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> The morphological features of s-IBM are vacuolar degeneration of muscle fibers, various degrees of lymphocytic inflammation, and intracellular congophilia. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> An intriguing aspect is that the pathological phenotypes of muscle in s-IBM and of brain in Alzheimer's disease (AD) share many similarities. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> Those include intramuscle fiber clusters (tangles) of paired helical filaments (PHFs) containing phosphorylated tau <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref> and abnormal accumulations of several proteins, such as amyloid-␤ precursor protein (A␤PP), including its epitope amyloid-␤, apolipoprotein E, ubiquitin, presenilin, and others. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> Similarly to AD brain, <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref> IBM abnormal muscle fibers express markers of oxidative stress. <ref type="bibr">10 -12</ref> Unknown in both IBM and AD are the factors leading to the abnormal accumulation of various proteins in the respective tissues, including the yet unidentified molecular pathways responsible for PHF formation. Recently it was demonstrated that AD neurofibrillary tangles (composed of PHFs) contain RNA <ref type="bibr" target="#b12">13</ref> and that RNA in vitro promotes assembly of tau into PHFs. <ref type="bibr" target="#b13">14</ref> We have now determined that clusters of IBM-PHFs contain RNA and a known RNA-binding protein, survival motor neuron (SMN). <ref type="bibr" target="#b14">15</ref> We previously demonstrated that in human muscle biopsies SMN is expressed at normal neuromuscular junctions postsynaptically <ref type="bibr" target="#b15">16</ref> in regenerating muscle fibers and in denervated, very atrophic, apoptotic-like fibers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p>Studies were performed on 10-m transverse sections of fresh-frozen diagnostic muscle biopsies of 19 patients with these diagnoses: 11 s-IBM, 2 non-IBM vacuolar myopathies of unknown cause, 3 morphologically nonspecific myopathies, 1 polymyositis, 2 dermatomyositis, and 4 normal muscle biopsies. All IBM biopsies had muscle fibers containing tau-positive PHFs and congophilia. <ref type="bibr" target="#b0">1</ref> rehydrated, rinsed, incubated in 1% acetic acid, rinsed, and stained for 3 minutes in 0.01% AO in 0.1 mol/L phosphate buffer, pH 6.0. The sections were then rinsed, incubated 1 minute in 0.1 mol/L calcium chloride, rinsed, and mounted in phosphate buffer. Fluorescence microscopy used a Zeiss Axiophot microscope with a BP 450 -490 exciter filter, LP 520 barrier filter, and FT 510 chromatic beam-splitter.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Double Localization of AO and SMI-31 Immunoreactivity on the Same Section</head><p>Sections were incubated for 1 hour in SMI-31 mouse monoclonal antibody (Sternberger Monoclonals Inc., Baltimore, MD, diluted 1:1000), which recognizes phosphorylated tau in IBM PHFs, <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b17">18</ref> followed by incubation in a rabbit anti-mouse serum conjugated to 7-amino-4-methylcoumarin-3-acetic acid (AMCA) (DAKO, Carpinteria, CA). Subsequently the sections were rinsed, fixed in ether: 95% ethanol (1:1), and processed for AO staining as above. The blue color of AMCA was visualized with a G 365 exciter filter, LP 420 barrier filter and FT 395 chromatic beam-splitter, and the orange color of AO histofluorescence was visualized as above.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SMN Immunocytochemistry</head><p>For light microscopy, SMN was immunolocalized using two mouse monoclonal anti-SMN antibodies: 2B1, a gift from Dr. Gideon Dreyfuss, diluted 1:50, and an antibody directed against residues 14 -174 of human SMN (Transduction Laboratories, Lexington, KY), diluted 1:20. We have previously described immunocytochemistry of SMN and its specificity in non-IBM human muscle biopsies. <ref type="bibr" target="#b15">16</ref> Electronmicroscopic immunocytochemistry of SMN was performed according to our previously established technique. <ref type="bibr">4 -6,18,19</ref> Figure 1. Fluorescence microscopy of acridine orange (AO) staining (RNA is orange, DNA bright yellow-green) and SMI-31 immunocytochemistry (bluish color), localizing IBM PHFs. A؊D, F, H, J, and L illustrate orange squiggly, rod-like and dot-like inclusions in IBM-abnormal muscle fibers. Pairs D and E (low-power microscopy), F and G, H and I (high-power microscopy) show double localization of AO and SMI-31. There is close colocalization of AO-positive orange RNA and bluish SMI-31 immunoreactive PHFs. K and M: Serial sections to J and L. AO-positive orange PHF inclusions (J and L) are not present after RNase pretreatment (K and M). J-M were photographed at the same exposure time; the darker background of K and M results from the elimination of the slight diffuse non-PHF RNA species within the muscle fibers. Original magnifications, ϫ1250 (A, B, D, E, J؊M), ϫ2000 (C), and ϫ7000 (F؊I).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Control Experiments</head><p>To evaluate whether orange AO histofluorescence was specific to RNA, before AO staining the sections were pretreated for 4 hours at 37°C with either 200 U/ml RNase-A solution (Ambion Inc., Austin, TX), containing 20 mmol/L of the protease-inhibitor phenylmethylsulfonyl fluoride (PMSF; Sigma, St. Louis, MO), or 10,000 U/ml RNase-free DNase solution (Roche Molecular Biochemicals, Indianapolis, IN). To determine whether SMN immunoreactivity reflects binding of the antigen to RNA, SMN immunohistochemistry was performed after the sections were pretreated with RNase solution as above. To block nonspecific binding of antibodies to Fc receptors, the sections were preincubated in normal goat serum diluted 1:10, as described. <ref type="bibr">4 -6,16,18,19</ref> Omission of the primary antibody or replacement of the primary antibody with a nonrelevant serum controlled for specificity of the immunohistochemical reactions, as described. <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AO Staining</head><p>AO positivity in this study refers only to the orange fluorescence of RNA. In s-IBM, 70 to 80% of the vacuolated muscle fibers (VMFs), and some of the non-VMFs, had AO positivity in the form of focal, well-demarcated squiggly, rod-like, and dot-like cytoplasmic inclusions (Figure <ref type="figure">1, AϪD, F, H, J, and L</ref>). Pretreatment with RNase-A, but not with DNase, completely abolished the AO positivity of more than 95% of the inclusions (Figure <ref type="figure">1</ref>, KϪM); rare inclusions retained weakly positive AO staining.</p><p>Normal muscle biopsies did not have any AO-positive muscle fibers. In regenerating muscle fibers of all biopsies that contained them, AO positivity was present in a diffuse pattern, and pretreatment with RNase-A completely abolished their AO positivity. Non-IBM vacuolar myopathies did not have AO-positive inclusions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Double Localization of AO Positivity and SMI-31 Immunoreactivity</head><p>In all IBM muscle biopsies, AO positivity of the cytoplasmic inclusions colocalized with SMI-31 immunoreactivity (Figure <ref type="figure">1</ref>, DϪI). Pretreatment with RNase-A did not influence the SMI-31 immunoreactivity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SMN Immunoreactivity</head><p>By light microscopy, 70 to 80% of the IBM-VMFs, and some of the non-VMFs, had strongly SMN-immunoreactive squiggly, rod-like, and dot-like inclusions (Figure <ref type="figure" target="#fig_0">2</ref>, AϪC and E). RNase pretreatment performed on serial sections either abolished or prominently diminished SMN immunoreactivity (Figure <ref type="figure" target="#fig_0">2</ref>, D and F). Ultrastructural immunocytochemistry of the IBM-VMFs revealed that SMN was immunolocalized only to the clusters of PHFs (Figure <ref type="figure" target="#fig_1">3, A and B</ref>). PHFs appear as tubulofilaments when horse-radish peroxidase is used as the immunohistochemical marker. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>Our study demonstrates that clusters of IBM-PHFs contain AO positivity and SMN immunoreactivity.</p><p>Under ultraviolet excitation, AO that is intercalated into RNA gives a bright orange fluorescence, whereas AO staining of DNA gives a yellow fluorescence. <ref type="bibr" target="#b19">20</ref> Cytoplasm lacking abundant RNA and DNA gives a pale green background. Individual subtypes of accumulated RNA (ie, mRNA, rRNA, tRNA) cannot be distinguished by this method. The IBM muscle biopsies emitted orange AO fluorescence of squiggly, rod-like, and dot-like inclusions against a pale green background of nonstained cytoplasm. RNase, but not DNase, pretreatment abolished the AO labeling of more than 95% of the inclusions, indicating that their AO positivity was specific for RNA. (The RNase pretreatment did not totally abolish orange fluorescence of the occasional inclusions, perhaps be- cause the RNase solution did not completely penetrate some tight clusters of PHFs, or because, in them, a fraction of RNA was more tightly complexed with PHF proteins.) The close colocalization of AO positivity with the immunoreactivity achieved with SMI-31 antibody recognizing IBM-PHFs suggests that the AO positivity reflects RNA on or within clusters of PHFs.</p><p>The mechanism of RNA accumulation within the clusters of IBM-PHFs is not known. In normal cells, some RNA associates with proteins of the cellular cytoskeleton. <ref type="bibr" target="#b20">21</ref> For example, the microtubule-associated protein MAP 1A is one component of the RNA-cytoskeleton complex. <ref type="bibr" target="#b21">22</ref> Normal tau is a microtubule-associated protein. When associated with tau, tubulin polymerizes into microtubules and by doing so prevents tau aggregation. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b22">23</ref> Phosphorylated tau (P-tau) has a decreased ability to interact with tubulin, a phenomenon proposed to be important in causing P-tau aggregation into PHFs in AD brain. <ref type="bibr" target="#b22">23</ref> Free RNA can compete with tubulin for the cellular pool of tau, and in vitro RNA stimulates aggregation of tau into PHFs. <ref type="bibr" target="#b13">14</ref> In IBM muscle fibers, possibilities include: i) that phosphorylation of tau diminishes its interaction with tubulin and increases its association with RNA, and this process facilitates formation of PHFs; ii) that RNA has an abnormal propensity to associate with tau, resulting in the pathological phosphorylation of tau and aggregation of it into PHFs; or iii) that RNA is being sequestered in the PHFs due to the presence there of a non-tau RNA-binding protein, eg, SMN.</p><p>SMN is a recently discovered protein, encoded by a gene on chromosome 5q13, mutations of which are associated with, and putatively responsible for, more than 98% of the autosomal-recessive spinal muscular atrophy patients. <ref type="bibr" target="#b23">24</ref> Normal biological functions of SMN are largely unknown, but SMN is known to bind directly to RNA and to RNA-binding proteins. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b24">25</ref> A role of SMN has also been proposed in RNA processing, in the biogenesis of small nuclear ribonucleic proteins, and in pre-mRNA splicing. <ref type="bibr" target="#b24">25</ref> In human muscle, SMN is developmentally regulated and, based on its immunolocalization, it probably plays a yet unknown role at normal nerve-muscle postsynaptic regions, in regenerating muscle fibers, and in post-denervation apoptosis-like processes of human muscle fibers. <ref type="bibr" target="#b15">16</ref> In IBM muscle the immunoreactivity of SMN was localized to PHFs, and it was abolished or greatly diminished after pretreatment with RNase. We therefore postulate that on PHFs the SMN is present, at least partially, through its association with RNA, and/or another protein already bound to PHF-linked RNA. For example, it would be interesting to determine whether small nuclear ribonucleoproteins (snRNPs) involved in spliceosome assembly are also accumulated within the clusters of PHFs, which might represent presumably inactive foci of these splicing elements.</p><p>PHFs in both AD brain and IBM muscle contain accumulation of several proteins, including markers of oxidative stress. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b25">26</ref> Molecular mechanisms leading to accumulation of those proteins and their role in the pathogenic cascade of both IBM and AD remain unknown. Several mechanisms, including RNA binding and oxidative damage, have been proposed in relation to PHF formation in AD brain. <ref type="bibr" target="#b13">14</ref> RNA has been shown to be oxidized in AD brain. <ref type="bibr" target="#b26">27</ref> Whether RNA is oxidized in IBM muscle fibers is not yet known.</p><p>Our present study demonstrates two novel components of IBM PHFs, and it raises the possibility that RNA and possibly the RNA-binding protein SMN participate in PHF formation in IBM. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. SMN immunoreactivity. A؊C, E: Darkly immunoreactive squiggly, rod-like, and dot-like inclusions in IBM abnormal muscle fibers. D and F: Serial sections to C and E; after pretreatment with RNase, SMN immunoreactivity is greatly diminished (D) or virtually eliminated (F). Arrows identify abnormal muscle fibers in D؊F. Original magnifications, ϫ1250.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Immunoelectronmicroscopy of SMN in two IBM-vacuolated muscle fibers. A and B: The peroxidase reaction demonstrates dark reaction-product covering PHFs exclusively and entirely, whereas adjacent portions of the myofiber (right side of each picture, identified by asterisk) are not immunostained. Original magnifications, ϫ28,000.</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="1152" xml:id="foot_0"> Broccolini et al  AJP April 2000, Vol. 156, No. 4   </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>We thank Dr. Gideon Dreyfuss for his gift of 2B1 anti-SMN antibody. Aldobrando Broccolini is a postdoctoral fellow in Dr. Askanas' laboratory.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain: recent approaches to diagnosis and pathogenesis, and relation to aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="389" to="405" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="389" to="405" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Amyloid filaments in inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1229" to="1234" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Light-and electronmicroscopic localization of ␤-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="774" to="786" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Widespread peroxynitrite-mediated damage in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Richey</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="2653" to="2657" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Oxidative posttranslational modifications in Alzheimer disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Monnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Chem Neuropathol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="41" to="48" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">␤-amyloid-associated free radical oxidative stress, and neurotoxicity: implications for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Butterfield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Res Toxicol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="495" to="506" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Immunolocalization of transcription factor NF-B in inclusion-body myositis muscle and at normal human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">254</biblScope>
			<biblScope unit="page" from="77" to="80" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: diseases of oxidative stress and aging?</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="915" to="920" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Sequestration of RNA in Alzheimer&apos;s disease neurofibrillary tangles and senile plaques</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Ginsberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Crino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vm-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Eberwine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="200" to="209" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kampers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Friedhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biernat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E-M</forename><surname>Mandelkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mandelkow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">399</biblScope>
			<biblScope unit="page" from="344" to="349" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Lorson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Androphy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1269" to="1275" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Localization of survival motor neuron protein in human apoptotic-like and regenerating muscle fibers, and neuromuscular junctions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1637" to="1641" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">A fluorescent microscopy study of biopsied muscles from infantile neuromuscular disorders</title>
		<author>
			<persName><forename type="first">T</forename><surname>Miike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tamari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohtani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Miyoshino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="48" to="52" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="389" to="391" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vm-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="889" to="895" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Schu ¨mmelfeder N: Histochemical significance of the polychromatic fluorescence induced in tissue stained with acridine orange</title>
	</analytic>
	<monogr>
		<title level="j">J Histochem Cytochem</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="392" to="393" />
			<date type="published" when="1958">1958</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">mRNA and cytoskeletal filaments</title>
		<author>
			<persName><forename type="first">G</forename><surname>Bassell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Singer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Cell Biol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="109" to="115" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A general RNA-binding protein complex that includes the cytoskeleton-associated protein MAP 1A</title>
		<author>
			<persName><forename type="first">C</forename><surname>Defranco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Chicurel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Potter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Biol Cell</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1695" to="1708" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Microtubule-associated protein/microtubule affinity-regulating kinase (p110 mark )</title>
		<author>
			<persName><forename type="first">G</forename><surname>Drewes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Trinczek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Illenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biernat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schmitt-Ulms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E-M</forename><surname>Mandelkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mandelkow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="7679" to="7688" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Identification and characterization of a spinal muscular atrophy-determining gene</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lefebvre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bu ¨rglen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Reboullet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Clermont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Burlet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Viollet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Benichou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cruaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Millasseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zeviani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Paslier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Weissenbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Munnich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Melki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="155" to="165" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pellizzoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kataoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Charroux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dreyfuss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="615" to="624" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Oxidative stress hypothesis in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Markesbery</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Free Radic Biol Med</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="134" to="147" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nunomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pappolla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hirai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1959" to="1964" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
